PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer

  • Lancet. 2021 Feb 27;397(10276):768-769. doi: 10.1016/S0140-6736(21)00349-4.
Thomas A Hope  1 ,  Jeremie Calais  2
Affiliations
  • 1. Department of Radiology and Biomedical Imaging and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; Department of Radiology and Biomedical Imaging, San Francisco VA Medical Center, San Francisco, CA, USA. Electronic address: [email protected].
  • 2. Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine and Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
PMID: 33581799 DOI: 10.1016/S0140-6736(21)00349-4
Products